Home
Atrial Fibrillation Study Brisbane WH 7003

Atrial Fibrillation Study

Momentum is conducting a clinical trial evaluating the effectiveness of a new blood thinner treatment intended to stop the formation of blood clots in people with atrial fibrillation, with a significantly reduced risk of bleeding.

Description

What to expect

Study details

Ages

18+ years old

Duration

A minimum duration of 3 months, with an expected duration of 2 years.

Compensation

Eligible participants will be compensated for time and travel-related costs.

Eligibility Criteria

You may be eligible to take part if you:

Are 18 years of age or older AND

Suffer from Atrial Fibrillation

Description

Blood thinners remain a cornerstone in the treatment for Atrial Fibrillation.

Atrial fibrillation (also knowns as AFib), is a common type of cardiac arrhythmia, which refers to an irregular heartbeat rhythm. As a result, the heart cannot pump blood effectively which can lead to a variety of symptoms, including palpitations, shortness of breath, and fatigue.

Without management, Atrial Fibrillation can lead to formation of blood clots, increasing the risk of stroke, heart failure, and other heart-related complications. Many blood-thinner therapies are currently available, but the disadvantage is that they can increase the risk of bleeding.

What to expect

Momentum is conducting a study evaluating the effectiveness of a new blood thinner treatment intended to stop the formation of blood clots in people with atrial fibrillation, with a significantly reduced risk of bleeding.

The study has a minimum duration of 3 months, with an expected duration of 2 years.

Eligible participants will be compensated for time and travel-related costs.

Apply now

Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.

*You can unsubscribe or opt out at any time.

1. We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.
2. We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.
3. Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.
4. All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.
5. By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.
6. There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.

Home
Atrial Fibrillation Study Brisbane WH 7003

Atrial Fibrillation Study

Description

What to expect

Study details

Ages

18+ years old

Duration

A minimum duration of 3 months, with an expected duration of 2 years.

Compensation

Eligible participants will be compensated for time and travel-related costs.

Eligibility Criteria

You may be eligible to take part if you:

Are 18 years of age or older AND

Suffer from Atrial Fibrillation

Description

Blood thinners remain a cornerstone in the treatment for Atrial Fibrillation.

What to expect

The study has a minimum duration of 3 months, with an expected duration of 2 years.

Eligible participants will be compensated for time and travel-related costs.

Apply now

Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.

*You can unsubscribe or opt out at any time.

1. We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.
2. We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.
3. Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.
4. All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.
5. By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.
6. There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.